TY - JOUR
T1 - FlowDock
T2 - A unified flow-based framework for flexible protein-ligand docking and binding affinity prediction
AU - Li, Jing
AU - Lu, Ruiqiang
AU - Tan, Yi
AU - Liang, Pengyu
AU - Liu, Bo
AU - Gu, Shukai
AU - Liu, Huanxiang
AU - Yao, Xiaojun
N1 - Publisher Copyright:
© 2026 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. This is an open access article under the CC BY-NC-ND license. http://creativecommons.org/licenses/by-nc-nd/4.0/
PY - 2026/7
Y1 - 2026/7
N2 - Accurate prediction of protein–ligand complexes and binding affinity is critical for hit identification and optimization for structure-based drug design. Traditional docking simulates binding processes with searching algorithms guided by energy-scoring functions, which are quite computationally expensive and time-intensive. In contrast, deep learning approaches offer a cost–effective alternative, yet often generate conformations with limited physicochemical validity and fail to account for protein flexibility. To address these pitfalls, we propose FlowDock, a multitask framework enhanced by Bayesian Flow Networks. FlowDock simultaneously generates accurate protein–ligand complex structures and predicts binding affinity while incorporating protein conformational flexibility. By leveraging multimodal intramolecular representations with a deep equivariant generative model, our method iteratively refines complex in latent space, ensuring rapid and stable generation. Benchmark evaluations demonstrate that FlowDock achieves state-of-the-art performance in binding pose prediction, especially physical plausibility, and virtual screening capability, alongside reliable binding affinity predictions. By providing deeper molecular insights into dynamic protein–ligand interactions, FlowDock represents a robust tool for accelerating the rational development of therapeutics.
AB - Accurate prediction of protein–ligand complexes and binding affinity is critical for hit identification and optimization for structure-based drug design. Traditional docking simulates binding processes with searching algorithms guided by energy-scoring functions, which are quite computationally expensive and time-intensive. In contrast, deep learning approaches offer a cost–effective alternative, yet often generate conformations with limited physicochemical validity and fail to account for protein flexibility. To address these pitfalls, we propose FlowDock, a multitask framework enhanced by Bayesian Flow Networks. FlowDock simultaneously generates accurate protein–ligand complex structures and predicts binding affinity while incorporating protein conformational flexibility. By leveraging multimodal intramolecular representations with a deep equivariant generative model, our method iteratively refines complex in latent space, ensuring rapid and stable generation. Benchmark evaluations demonstrate that FlowDock achieves state-of-the-art performance in binding pose prediction, especially physical plausibility, and virtual screening capability, alongside reliable binding affinity predictions. By providing deeper molecular insights into dynamic protein–ligand interactions, FlowDock represents a robust tool for accelerating the rational development of therapeutics.
KW - Bayesian flow networks
KW - Binding affinity prediction
KW - Deep equivariant generative models
KW - Latent space optimization
KW - Machine learning in drug discovery
KW - Protein–ligand docking
KW - Structure-based drug design
UR - https://www.scopus.com/pages/publications/105037742555
U2 - 10.1016/j.apsb.2026.04.009
DO - 10.1016/j.apsb.2026.04.009
M3 - Article
AN - SCOPUS:105037742555
SN - 2211-3835
VL - 16
SP - 4067
EP - 4082
JO - Acta Pharmaceutica Sinica B
JF - Acta Pharmaceutica Sinica B
IS - 7
ER -